Columbia Research Beta vs. One Year Return

REVS Etf  USD 26.96  0.01  0.04%   
Considering the key profitability indicators obtained from Columbia Research's historical financial statements, Columbia Research Enhanced may not be well positioned to generate adequate gross income at the present time. It has a very high likelihood of underperforming in December. Profitability indicators assess Columbia Research's ability to earn profits and add value for shareholders.
For Columbia Research profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Columbia Research to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Columbia Research Enhanced utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Columbia Research's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Columbia Research Enhanced over time as well as its relative position and ranking within its peers.
  
Check out Your Equity Center.
The market value of Columbia Research is measured differently than its book value, which is the value of Columbia that is recorded on the company's balance sheet. Investors also form their own opinion of Columbia Research's value that differs from its market value or its book value, called intrinsic value, which is Columbia Research's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Columbia Research's market value can be influenced by many factors that don't directly affect Columbia Research's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Columbia Research's value and its price as these two are different measures arrived at by different means. Investors typically determine if Columbia Research is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Columbia Research's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Columbia Research One Year Return vs. Beta Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Columbia Research's current stock value. Our valuation model uses many indicators to compare Columbia Research value to that of its competitors to determine the firm's financial worth.
Columbia Research Enhanced is presently regarded as number one ETF in beta as compared to similar ETFs. It also is presently regarded as number one ETF in one year return as compared to similar ETFs reporting about  39.28  of One Year Return per Beta. Comparative valuation analysis is a catch-all technique that is used if you cannot value Columbia Research by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Columbia One Year Return vs. Beta

Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.

Columbia Research

Beta

 = 

Covariance

Variance

 = 
0.83
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
One Year Return is the annualized return generated from holding a security for exactly 12 months. The measure is considered to be good short-term measures of fund performance. In other words, it represents the capital appreciation of fund investments over the last year. However when the market is volatile such as in recent years, One Year Return measure can be misleading.

Columbia Research

One Year Return

 = 

(Mean of Monthly Returns - 1)

X

100%

 = 
32.60 %
Although One Year Fund Return indicator can give a sense of overall fund short-term potential, it is recommended to look at mid and long term return measure before selecting a particular fund or ETF. The great way to validate fund short-term performance is to compare it with other similar funds or ETFs for the same 12 months interval.

Columbia One Year Return Comparison

Columbia Research is currently under evaluation in one year return as compared to similar ETFs.

Beta Analysis

As returns on the market increase, Columbia Research's returns are expected to increase less than the market. However, during the bear market, the loss of holding Columbia Research is expected to be smaller as well.

Columbia Research Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Columbia Research, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Columbia Research will eventually generate negative long term returns. The profitability progress is the general direction of Columbia Research's change in net profit over the period of time. It can combine multiple indicators of Columbia Research, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
The fund invests at least 80 percent of its assets in the securities of the index. Columbia Research is traded on NYSEARCA Exchange in the United States.

Columbia Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Columbia Research. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Columbia Research position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Columbia Research's important profitability drivers and their relationship over time.

Use Columbia Research in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Columbia Research position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Columbia Research will appreciate offsetting losses from the drop in the long position's value.

Columbia Research Pair Trading

Columbia Research Enhanced Pair Trading Analysis

The ability to find closely correlated positions to Columbia Research could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Columbia Research when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Columbia Research - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Columbia Research Enhanced to buy it.
The correlation of Columbia Research is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Columbia Research moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Columbia Research moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Columbia Research can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Columbia Research position

In addition to having Columbia Research in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Health Care ETFs Thematic Idea Now

Health Care ETFs
Health Care ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Health Care ETFs theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Health Care ETFs Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Columbia Research is a strong investment it is important to analyze Columbia Research's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Columbia Research's future performance. For an informed investment choice regarding Columbia Etf, refer to the following important reports:
Check out Your Equity Center.
You can also try the CEOs Directory module to screen CEOs from public companies around the world.
To fully project Columbia Research's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Columbia Research at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Columbia Research's income statement, its balance sheet, and the statement of cash flows.
Potential Columbia Research investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Columbia Research investors may work on each financial statement separately, they are all related. The changes in Columbia Research's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Columbia Research's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.